Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663767 · ClinicalTrials.gov registry record · Phase 2
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
A Phase 2 study of Dental Pain, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT00663767: Completed Phase 2 study of Dental Pain, sponsored by Pfizer.
NCT00663767 is a Phase 2 study of Dental Pain that has completed, run by Pfizer. The registered enrollment target is 250 participants, above the 204-participant average among 6 other Dental Pain trials with a reported enrollment target (23% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00663767, a Phase 2 study of Dental Pain, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain in a postoperative pain model (third molar extraction), and to further evaluate the drug's safety. Approximately 250 subjects from the US will be enrolled in this study.
Conditions Studied
Interventions
- DRUG ARRY-371797, p38 inhibitor; oral
- DRUG Placebo; oral
- DRUG Celecoxib, COX-2 inhibitor; oral
Study Locations (2)
Texas
- PPD Phase I Clinic - Austin
Utah
- Lifetree Clinical Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2008-04-07 |
| Est. Completion | 2008-06-20 |
| Phase | Phase 2 |
What the finished NCT00663767 record still lists
NCT00663767 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 204-participant average among 6 other Dental Pain trials with a reported enrollment target (23% higher).
The record links to 1 condition, with Dental Pain appearing as the primary indexed condition, and to 3 interventions - of which ARRY-371797, p38 inhibitor; oral is the first listed.
NCT00663767 reports a single indexed study location in Texas, Utah.
Frequently Asked Questions
What is clinical trial NCT00663767 about?
NCT00663767 is a clinical study titled "A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction". This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain in a postoperative pain model (third molar extraction), and to further evaluate the drug's safety. Approximately 250 subjects from the US will be enrolled in this study.
What is the current status of trial NCT00663767?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 250 participants. The study started on 2008-04-07. Estimated completion is 2008-06-20.
What conditions does trial NCT00663767 study?
This clinical trial studies the following conditions: Dental Pain.
What interventions are being tested in trial NCT00663767?
The interventions under investigation include: ARRY-371797, p38 inhibitor; oral (DRUG), Placebo; oral (DRUG), Celecoxib, COX-2 inhibitor; oral (DRUG).
Who is sponsoring clinical trial NCT00663767?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00663767 being conducted?
This trial has 2 study locations across Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
COMPLETED · Phase 2
-
Exploration of the Utility of Dental-dedicated MRI for Dentistry
RECRUITING
-
Photobiomodulation and Tooth Analgesia
RECRUITING · NA
-
Dental Block for Pain Relief in ED Dental Pain Patients
RECRUITING
-
Dental Pain (Following Third Molar Tooth Extraction) Study
COMPLETED · Phase 3
-
Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI